184 related articles for article (PubMed ID: 25294223)
1. Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: an open-label pilot study.
Waki N; Matsumoto M; Fukui Y; Suganuma H
Lett Appl Microbiol; 2014 Dec; 59(6):565-71. PubMed ID: 25294223
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection.
Waki N; Yajima N; Suganuma H; Buddle BM; Luo D; Heiser A; Zheng T
Lett Appl Microbiol; 2014 Jan; 58(1):87-93. PubMed ID: 24329975
[TBL] [Abstract][Full Text] [Related]
3. Effects of Heat-Killed
Satomi S; Waki N; Arakawa C; Fujisawa K; Suzuki S; Suganuma H
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578917
[TBL] [Abstract][Full Text] [Related]
4. Short Communication: Oral Administration of Heat-killed
Satomi S; Khanum S; Miller P; Suzuki S; Suganuma H; Heiser A; Gupta SK
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32987850
[TBL] [Abstract][Full Text] [Related]
5. Cell-bound exopolysaccharides of Lactobacillus brevis KB290 enhance cytotoxic activity of mouse splenocytes.
Sasaki E; Suzuki S; Fukui Y; Yajima N
J Appl Microbiol; 2015 Feb; 118(2):506-14. PubMed ID: 25376258
[TBL] [Abstract][Full Text] [Related]
6. Relation between cell-bound exopolysaccharide production via plasmid-encoded genes and rugose colony morphology in the probiotic Lactobacillus brevis KB290.
Fukao M; Zendo T; Inoue T; Fuke N; Moriuchi T; Yamane Y; Nakayama J; Sonomoto K; Fukaya T
Anim Sci J; 2019 Dec; 90(12):1575-1580. PubMed ID: 31593351
[TBL] [Abstract][Full Text] [Related]
7. Teratogenicity and maternal effects of Lactobacillus brevis KB290 in rats and rabbits.
Yakabe T; Takashima H; Kuwagata M; Fukao M; Kikuchi S; Yajima N
Food Chem Toxicol; 2011 Apr; 49(4):722-6. PubMed ID: 21112368
[TBL] [Abstract][Full Text] [Related]
8. Assessment of antibiotic resistance in probiotic strain Lactobacillus brevis KB290.
Fukao M; Tomita H; Yakabe T; Nomura T; Ike Y; Yajima N
J Food Prot; 2009 Sep; 72(9):1923-9. PubMed ID: 19777895
[TBL] [Abstract][Full Text] [Related]
9. Safety assessment of Lactobacillus brevis KB290 as a probiotic strain.
Yakabe T; Moore EL; Yokota S; Sui H; Nobuta Y; Fukao M; Palmer H; Yajima N
Food Chem Toxicol; 2009 Oct; 47(10):2450-3. PubMed ID: 19583990
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of Citrobacter rodentium proliferation in early stage of infection in mice by pretreatment with Lactobacillus brevis KB290 and verification using in vivo bioluminescence imaging.
Waki N; Kuwabara Y; Yoshikawa Y; Suganuma H; Koide H; Oku N; Ohashi N
FEMS Microbiol Lett; 2017 Mar; 364(6):. PubMed ID: 28333177
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus brevis KB290 enhances IL-8 secretion by Vibrio parahaemolyticus-infected Caco-2 cells.
Yakabe T; Shimohata T; Takahashi A
J Microbiol Biotechnol; 2013 Jan; 23(1):118-24. PubMed ID: 23314377
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined consumption of Lactobacillus brevis KB290 and β-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects: a randomised, double-blind, placebo-controlled, parallel-group trial.
Fuke N; Aizawa K; Suganuma H; Takagi T; Naito Y
Int J Food Sci Nutr; 2017 Dec; 68(8):973-986. PubMed ID: 28391736
[TBL] [Abstract][Full Text] [Related]
13. Genomic analysis by deep sequencing of the probiotic Lactobacillus brevis KB290 harboring nine plasmids reveals genomic stability.
Fukao M; Oshima K; Morita H; Toh H; Suda W; Kim SW; Suzuki S; Yakabe T; Hattori M; Yajima N
PLoS One; 2013; 8(3):e60521. PubMed ID: 23544154
[TBL] [Abstract][Full Text] [Related]
14. Sequential gene expression profiling in the mouse spleen during 14 d feeding with Lactobacillus brevis KB290.
Fukui Y; Sasaki E; Fuke N; Nakai Y; Ishijima T; Abe K; Yajima N
Br J Nutr; 2014 Jun; 111(11):1957-66. PubMed ID: 24576393
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus brevis KB290 With Vitamin A Ameliorates Murine Intestinal Inflammation Associated With the Increase of CD11c+ Macrophage/CD103- Dendritic Cell Ratio.
Fuke N; Takagi T; Higashimura Y; Tsuji T; Umeda R; Mizushima K; Tanaka M; Suganuma H; Aizawa K; Yajima N; Naito Y
Inflamm Bowel Dis; 2018 Jan; 24(2):317-331. PubMed ID: 29361084
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-encoded glycosyltransferase operon is responsible for exopolysaccharide production, cell aggregation, and bile resistance in a probiotic strain, Lactobacillus brevis KB290.
Fukao M; Zendo T; Inoue T; Nakayama J; Suzuki S; Fukaya T; Yajima N; Sonomoto K
J Biosci Bioeng; 2019 Oct; 128(4):391-397. PubMed ID: 31126721
[TBL] [Abstract][Full Text] [Related]
17. Heat-killed Lactobacillus brevis KB290 attenuates visceral fat accumulation induced by high-fat diet in mice.
Watanabe J; Hashimoto N; Yin T; Sandagdorj B; Arakawa C; Inoue T; Suzuki S
J Appl Microbiol; 2021 Oct; 131(4):1998-2009. PubMed ID: 33742756
[TBL] [Abstract][Full Text] [Related]
18. Growth characteristics of Lactobacillus brevis KB290 in the presence of bile.
Kimoto-Nira H; Suzuki S; Suganuma H; Moriya N; Suzuki C
Anaerobe; 2015 Oct; 35(Pt B):96-101. PubMed ID: 26272823
[TBL] [Abstract][Full Text] [Related]
19. The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial.
Murakami K; Habukawa C; Nobuta Y; Moriguchi N; Takemura T
Biopsychosoc Med; 2012 Aug; 6(1):16. PubMed ID: 22863114
[TBL] [Abstract][Full Text] [Related]
20. Cell-bound exopolysaccharides of Lactobacillus brevis KB290: protective role and monosaccharide composition.
Suzuki S; Yakabe T; Suganuma H; Fukao M; Saito T; Yajima N
Can J Microbiol; 2013 Aug; 59(8):549-55. PubMed ID: 23898998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
